China
Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases
COVID-19, Mesenchymal stem cells, Randomised controlled trial
Keywords:COVID-19, Mesenchymal stem cell Therapy, 3-year follow-up, Long-COVID